ClearPoint Neuro, Inc. — Director's Dealing 2021

Aug 5, 2021

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: ClearPoint Neuro, Inc. (CLPT)
CIK: 0001285550
Period of Report: 2021-07-23

Reporting Person: Piferi Peter G. (Chief Operating Officer)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2021-07-23	Common Stock	M	3141	$3.24	Acquired	40085	Direct
2021-07-23	Common Stock	M	4464	$3.47	Acquired	44549	Direct
2021-07-23	Common Stock	M	20000	$2.60	Acquired	64549	Direct
2021-07-23	Common Stock	F	3856	$20.15	Disposed	60693	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2021-07-23	Stock Options (right to buy)	$3.24	M	3141	Disposed	2030-07-09	Common Stock (3141)	Direct
2021-07-23	Stock Options (right to buy)	$3.47	M	4464	Disposed	2029-08-15	Common Stock (4464)	Direct
2021-07-23	Stock Options (right to buy)	$2.60	M	20000	Disposed	2027-10-04	Common Stock (20000)	Direct